Panacea Life Sciences Holdings, Inc. (PLSH)
Panacea Life Sciences Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Greenwood Village, CO, US. The stock last traded at $0.10, up 6.72% on the session, giving a market capitalisation of $2.1M. On trailing twelve-month figures it carries a trailing P/E of -2.40, a net margin of -916.7%. Its beta of 2.54 implies it has historically moved more than the broad market.
Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.
Panacea Life Sciences Holdings, Inc. is most often compared with the following Healthcare names: